| Turchia | Austria | Spanyol | |
| Trattamento complesso del cancro alla tiroide | - | - | da $5,894 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Trattamento complesso del cancro alla tiroide. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Trattamento complesso del cancro alla tiroide al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Trattamento complesso del cancro alla tiroide e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Trattamento complesso del cancro alla tiroide.
Dr. Jose Maria Raventos is a surgeon with 49 years of experience. He specializes in general, abdominal, endocrine, and thyroid surgery. He is known for his advanced laparoscopic skills. Dr. Raventos is also highly experienced in thyroid surgery, including complex thyroid cancer cases.
He has made important contributions to surgical research and education. He has published many scientific articles and is active in several professional associations. Dr. Raventos earned his medical degrees from the University of Barcelona and the University of Minnesota. He completed his residencies at the Red Cross Hospital of Barcelona and the Mayo Clinic in Rochester. He is a founding member of the Teknon Medical Center faculty and the Surgical Associate Surgeons group.
Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.
Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.